Cargando...
Cost–utility analysis of 21-gene assay for node-positive early breast cancer
BACKGROUND: For women with lymph node (ln)–positive, estrogen receptor–positive, and her2 (human epidermal growth factor receptor 2)–negative breast cancer (bca), current guidelines recommend treatment with both hormonal therapy and chemotherapy. The 21-gene Recurrence Score (rs) assay might be help...
Guardado en:
| Publicado en: | Curr Oncol |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Multimed Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6821112/ https://ncbi.nlm.nih.gov/pubmed/31708649 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.26.4769 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|